Treatment of Liver Fibrosis in Adults with Nonalcoholic Steatohepatitis (NASH)

NASH is liver inflammation and damage caused by a buildup of fat in the liver. Learn More

Phase: III

Age requirements: 18- 75 years of age

Compensation available

Key Inclusion Criteria:

  • Male and female subjects aged between 18-75 years.
  • Histological evidence of NASH.
  • Histological evidence of Stage 2 or 3 liver fibrosis.
  • Historical biopsy was obtained no more than 180 days prior to the first day of screening.
  • Females of childbearing potential and males participating in the study must agree to use at least 2 approved methods of contraception throughout the duration of the study and for 30 days after stopping study drug.
  • Females who are postmenopausal must have documentation of cessation of menses for ≥12 months without an alternative medical cause.

Additional Criteria:
At screening visit, additional criteria will be reviewed to determine eligibility for the study. Qualified participants will receive study medication, medical care and compensation for the time and travel of each completed study visit.

Back to list


Thank you for your interest in our studies. Please use the following form to begin your enrollment process in a clinical trial or to join our database of opted-in patients. You will receive notification via email and/or regular mail about new clinical trial opportunities.

Fields marked with an asterisk (*) are required.

I am interested in the following studies:

By completing this form, you are not committing to participate in a clinical research study or being selected as a study participant. You will be given the option to select whether or not you'd like to be considered for potential participation.